Leap Therapeutics
LPTX
LPTX
70 hedge funds and large institutions have $43.2M invested in Leap Therapeutics in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 19 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
13% less funds holding
Funds holding: 80 → 70 (-10)
41% less capital invested
Capital invested by funds: $73.9M → $43.2M (-$30.6M)
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
Holders
70
Holding in Top 10
1
Calls
$411K
Puts
$39K
Top Buyers
| 1 | +$714K | |
| 2 | +$608K | |
| 3 | +$441K | |
| 4 |
KCFA
Key Client Fiduciary Advisors
Fairfield,
New Jersey
|
+$405K |
| 5 |
DAM
DLD Asset Management
New York
|
+$288K |
Top Sellers
| 1 | -$2.11M | |
| 2 | -$1.74M | |
| 3 | -$907K | |
| 4 |
Morgan Stanley
New York
|
-$715K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$681K |